primary%20angle-closure%20glaucoma
PRIMARY ANGLE-CLOSURE GLAUCOMA
Primary angle-closure is the synechial or appositional closure of the anterior chamber angle secondary to multiple mechanisms resulting in raised intraocular pressure and structural changes in the eyes.
Iridotrabecular contact is the hallmark of primary angle-closure  and the most commonly identified sign which indicates that treatment is required.
It is defined by at least 180 degrees of iridotrabecular contact together with an elevated intraocular pressure or peripheral anterior synechiae or btoh
Primary angle-closure glaucoma is the presence of glaucomatous optic neuropathy.
  1. Canadian Ophthalmological Society. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009;44(Suppl 1):S3-S54. Accessed 10 Feb 2012. PMID: 19492005
  2. Broan AM, Garcger CP, Sirbat D, et al. Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group. Eur J Ophthalmol. 1997;7(4):351-356. Accessed 10 Feb 2012. PMID: 9457458
  3. Demailly P, Allaire C, Bron V, Trinquand C. Effectiveness and tolerance of beta blocker/pilocarpine combination eye drops in primary open-angle glaucoma and high intraocular pressure. J Glaucoma. 1995 Aug;4(4):235-241. Accessed 10 Feb 2012. PMID: 19920680
  4. European Glaucoma Society. Terminology and guidelines in glaucoma. 3rd. Italy: European Glaucoma Society; 2008.
  5. South East Asia Interest Group. Asia Pacific glaucoma guidelines. 2nd ed. Sydney, Australia: SEAGIG; 2008
  6. See JL, Chew PTK. Angle-closure glaucoma. In: Yanoff M, Duker JS, et al. Ophthalmology. 3rd ed. Maryland Heights, MO: Mosby, Elsevier; 2009:1162-1171
  7. International Council of Ophthalmology. Primary angle closure (initial evaluation and therapy). International Council of Ophthalmology. http://www.icoph.org/dynamic/attachments/resources/icopriangleclosure_2.pdf. 2010. Accessed 28 Aug 2012.
  8. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern Guidelines. Primary angle closure. San Francisco, CA: American Academy of Ophthalmology. http://one.aao.org/preferred-practice-pattern/primary-angle-closure-ppp--october-2010. 2010. Accessed 22 Aug 2012
  9. Japan Glaucoma Society. Guidelines for glaucoma. 2nd ed. Japan Glaucoma Society. http://ryokunaisho.jp/english/Guidelines_for_Glaucoma.pdf. Sep 2006. Accessed 31 Aug 2012.
  10. American Optometric Association. Primary angle closure glaucoma. http://www.aoa.org/documents/CPG-5.pdf. 1994. Accessed 03 Sep 2012
  11. Cheng JW, Zong Y, Zeng YY, et al. The prevalence of primary angle closure glaucoma in adult Asians: a systematic review and meta-analysis. PLoS One. 2014 Jul 24;9(7):e103222. doi: 10.1371/journal.pone.0103222. Accessed 22 Sep 2015. PMID: 5057993
  12. Emanuel ME, Parrish RK 2nd, Gedde SJ. Evidence-based management of primary angle closure glaucoma (abstract). Curr Opin Ophthalmol. 2014 Mar;25(2):89-92. doi: 10.1097/ICU.0000000000000028. Accessed 24 Sep 2015. PMID: 24463418
  13. Muñoz-Negrete FJ, González-Martín-Moro J, Casas-Llera P, et al. Guidelines for treatment of chronic primary angle-closure glaucoma. Arch Soc Esp Oftalmol. 2015 Mar;90(3):119-138. doi: 10.1016/j.oftal.2014.09.014. Accessed 22 Sep 2015. PMID: 25459683
  14. Weizer JS. Angle-closure glaucoma. UpToDate. http://www.uptodate.com/contents/angle-closure-glaucoma. 04 Nov 2014.
  15. European Glaucoma Society (EGS). Terminology and guidelines for glaucoma. 4th ed. EGS. http://www.eugs.org/eng/EGS_guidelines4.asp. Jun 2014.
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, Yesterday

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
Stephen Padilla, 12 Sep 2019
Overweight and obesity show an inverse relationship with acne in a dose-dependent manner in young adults, according to a recent study. This suggests that the metabolically active adipose tissue plays a protective role in acne.